Dr Nupur Mukherjee

Scientist B

Email: mukherjeen[at]nirrh[dot]res[dot]in, nupurmukherjee10[at]gmail[dot]com
Phone: 022-24192172
Department: Innate Immunity

Academic Background

B.Sc., Biophysics, Panjab University, 2002.

M.Sc., Biophysics, Panjab University, Chandigarh 2004.

Ph. D., Life Science, Jadavpur University, Kolkata, 2012.

Professional Experience

Research Associate (CSIR-HRDG)

Dept. of Oncogene Regulation,Chittaranjan National Cancer Institute Kolkata, India

2013- 2016

Postdoctoral Scientist

National Institute of Cell Biotechnology, Dublin City University, Dublin, Ireland

2016- 2017

Scientist B

ICMR-NIRRH

2017-till date

Research Interests

Role of Innate Immune Regulation in Prostrate Cancer
Role of stem cells and associated signalling pathways in Dug resistance in Prostrate and breast cancer

Awards & Achievements

Publications

Projects

Publications

1. Gaule P, Mukherjee N, Corkery B, Eustace AJ, Gately K, Roche S, O’Connor R, O’Byrne KJ, Walsh N, Duffy MJ, Crown J, O’Donovan N. Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells. Cancers (Basel). 2019 Apr 17;11(4)
2. Mukherjee N, Dasgupta H, Bhattacharya R, Pal D, Roy R, Islam S, Alam N, Biswas J, Roy A, Roychoudhury S, Panda CK Frequent inactivation of MCC/CTNNBIP1 and overexpression of phospho-beta-catenin(Y654) are associated with breast carcinoma: Clinical and prognostic significance. 2016; 1862(9):1472-84.
3. Mukherjee N, Islam MS, Roychowdhury A, Bhattacharya R, Chunder N, Bhattacharya N, Sinha S, Alam N, Roy A, Roychoudhury S, Panda CK. The stem cell renewal and DNA damage response pathways are frequently altered in fibroepithelial tumors of breast in Indian patients. Pathol Res Pract. 2016 Mar; 212(3):196-203.
4. Mukherjee N, Bhattacharya N, Alam N, Roy A, Roychoudhury S, Panda CK. Subtype specific alterations of Wnt signaling pathway in breast cancer: clinical and prognostic significance. Cancer Sci. 2012 Feb; 103(2):210-20.
5. Mukherjee N, Bhattacharya N, Sinha S, Alam N, Chakravarti R, Roychoudhury S, Panda CK. Association of APC and MCC genes polymorphism with increased breast cancer risk in Indian population. Int J Biol Markers 2011; 26 (1): 43-49.
6. Bhattacharya R, Mukherjee N, Dasgupta H, Islam S, Alam N, Roy A, Das P, Roychoudhury S, Panda CK. Frequent alterations of SLIT2-ROBO1-CDC42 signaling pathway in breast cancer: clinicopathological correlation. Journal of Genetics.
7. Dasgupta H, Mukherjee N, Islam S, Bhattacharya R, Alam N, Roy A, Roychoudhury S, Biswas J, Panda CK. Frequent alterations of homologous recombination repair pathway in primary and chemotolerant breast carcinomas: clinical importance. Future Oncol. 2016 Sep 20. [Epub ahead of print]
8. Bhattacharya N, Mukherjee N, Singh RK, Sinha S, Alam N, Roy A, Roychoudhury S, Panda CK. Frequent Alterations of MCPH1 and ATM are Associated with Primary Breast Carcinoma: Clinical and Prognostic Implications. Ann Surg Oncol. 2013;20 Suppl 3:S424-32.
9. Sanga Mitra, Nupur Mukherjee, Smarajit Das, Pijush Das, Chinmay Kumar Panda, & Jayprokas Chakrabarti. Anomalous altered expressions of downstream gene-targets in TP53-miRNA pathways in head and neck cancer. Scientific Reports 2014 Sci Rep. 2014; 4:6280.
10. Chakraborty C, Dutta S, Mukherjee N, Samadder S, Roychowdhury A, Roy A, Mondal RK, Basu P, Roychoudhury S, Panda CK. Inactivation of PTCH1 is associated with the development of cervical carcinoma: clinical and prognostic implication. Tumour Biol. 2015; 36(2):1143-54.
11. Maiti GP, Mondal P, Mukherjee N, Ghosh A, Ghosh S, Dey S, Chakrabarty J, Roy A, Biswas J, Roychoudhury S, Panda CK. Overexpression of EGFR in Head and Neck Squamous Cell Carcinoma Is Associated with Inactivation of SH3GL2 and CDC25A Genes. PLoS One. 2013;8(5):e63440.
12. Chatterjee A, Dutta S, Mukherjee S, Mukherjee N, Dutta A, Mukherjee A, Sinha S, Panda CK, Chaudhuri K, Roy AL, Mukhopadhyay K. Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies. BMC Med Genet. 2013;14(1):12. [Epub ahead of print].
13. Dey A, Chatterjee A, Maiti A, Mukherjee N, Sinha S, Panda CK, Mukhopadhyay K. Biased paternal transmission of TRH variant to female Down syndrome probands: possible correlation with low breast cancer frequency. Int J Biol Markers. 2015 Feb 24;30(1):e142-7.
14. Sinha S, Singh RK, Bhattacharya N, Mukherjee N, Ghosh S, Alam N, Roy A, Roychoudhury S, Panda CK. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications. Mol Oncol. 2011 Oct; 5(5):454-64.
15. Ashraf M, Jha JK, Mukherjee N, Panda CK, Nayak S, Jadhav TS, Dikshit N, Nath NC, Chakraborty J, Biswas J. BRCA1 protein expression and its correlation with ER/PR status in sporadic and familial breast cancer in Eastern Indian patients: a hospital based study. J Indian Med Assoc 2011; 109: 873-8.
16. Ghosh A, Ghosh S, Maiti GP, Mukherjee S, Mukherjee N, Chakraborty J, Roy A, Roychoudhury S, Panda CK. Association of FANCC and PTCH1 with the Development of Early Dysplastic Lesions of the Head and Neck. Ann Surg Oncol. 2011 Aug 23. [Epub ahead of print]
17. Ghosh S, Ghosh A, Maiti GP, Mukherjee N, Dutta S, Roy A, Roychoudhury S, Panda CK. LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: Clinical and prognostic implications. Molecular Cancer. 2010; 9, 58-71.
18. Chatterjee A, Dutta S, Mukherjee S, Mukherjee N, Chandra S, Mukherjee A, Sinha S, Panda CK, Chaudhuri K, Mukhopadyay K. Differential allelic distribution of V-ets erythroblastosis virus E26 oncogene homolog2 (ETS2) functional polymorphisms in different group of patients. Gene Expr. 2010; 15(2):61-73.
19. Chatterjee A, Mukherjee N, Panda CK and Mukhopadhyay K. Could allelic Discrimination In ETS2 Predispose individuals to Breast Cancer?.The Open Access Breast Cancer Journal. 2009; 1: 30-32.
20. Sinha S, Chunder N, Mukherjee N, Alam N, Roy A, Roychoudhury S, Kumar Panda C. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol. 2008; 15 (4):1070-80.
21. Koul A, Mukherjee N, Gangar SC. Inhibitory effects of Azadirachta indica on DMBA-induced skin carcinogenesis in Balb/c mice. Mol Cell Biochem. 2006; 283(1-2), 47-55.

Dr Nupur Mukherjee

Scientist B

Academic Background

Professional Experience

Research Interests

Awards & Achievements

Publications

Projects Ongoing